Dashboard
Performance
Stock Index
Insider Buying
Sectors & Industries
Sectors
Industries
Market Overview
Home
Market Dashboard
Scan Performance
Stock Index
Insider Buying
Sectors
Industries
My Watchlist
Alpha Watchlist
How It Works
Login
Get Started
Home
INCY
INCY Stock Chart: Technical Analysis & Trade Ideas for Incyte Corporation
Watchlist
INCY
$QUBT
$BMNR
$RGTI
$QBTS
$SERV
$ASTS
$CRCL
$LUMN
$SNDK
Recent INCY News
China Medical System (867.HK; 8A8.SG) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD Indication
GlobeNewswire Inc.
•
Sunday, September 28, 2025
Liposarcoma Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 15+ Companies and 20+ Therapies | DelveInsight
GlobeNewswire Inc.
•
Tuesday, May 27, 2025
Merus annonce ses résultats financiers pour le premier trimestre 2025 et fait le point sur ses activités
GlobeNewswire Inc.
•
Friday, May 9, 2025
Generic Oncology Drugs Market Size Estimated to Reach USD 30,998 Mn by 2034, Rising Global Cancer Cases Increase Demand for Affordable Treatments
GlobeNewswire Inc.
•
Wednesday, May 7, 2025
Atopic Dermatitis Drugs Market Forecast 2025-2034 | Rising Drug Approvals and Clinical Trial Successes Propel Revenue Growth, Making Atopic Dermatitis a High-Growth Market
GlobeNewswire Inc.
•
Friday, April 18, 2025
Why Incyte Stock Was Tanking This Week
The Motley Fool
•
Friday, March 21, 2025
Incyte Releases Mixed Data From Late-Stage Opzelura Studies In Skin Disease Characterized By Itchy Firm Lumps
Benzinga
•
Monday, March 10, 2025
Immunotherapy in Oncology Patent Landscape Report and Forecast 2024-2032: Identify Emerging Therapeutic Targets and Assess the Competitive Landscape
GlobeNewswire Inc.
•
Thursday, March 6, 2025
OPZELURA Continues to Revolutionize Dermatology Market with Strong Market Uptake | DelveInsight
GlobeNewswire Inc.
•
Friday, February 28, 2025
Incyte At JPM25: Eyes Transformational 2025 With Multiple Drug Launches And Expanding Pipeline
Benzinga
•
Tuesday, January 14, 2025
View More News
Technical Signal History: INCY
Incyte Corporation
Tuesday, April 21, 2026
The Strat 2 - 2 Down
Red Day Followed by a Bearish 2-Down Breakout That Closes Red
Analysis
Crossed Below 10 SMA
First Day Below 10 SMA After an Extended Run Above
Analysis
Biggest Percent Losers
Stocks With the Biggest Losses - Bearish Momentum and Risk Signals
Analysis
Monday, April 20, 2026
First Down Day After Most Up Days
First Down Day After the Longest Winning Streak
Analysis
Biggest Percent Losers
Stocks With the Biggest Losses - Bearish Momentum and Risk Signals
Analysis
Friday, April 17, 2026
RSI Crossed Above 50
Stocks Gaining Strength After Weakness - RSI Above 50
Analysis
The Strat 2 Up Reversal
Red Day Followed by a Bullish 2-Up Breakout That Closes Green
Analysis
Crossed Above 50 SMA After Extended Time
First Day Above 50 SMA After Extended Time Below 200 SMA
Analysis
Crossed Above 50 SMA
First Day Above 50 SMA After Extended Weakness
Analysis
Crossed Above 10 SMA
First Day Above 10 SMA After Extended Weakness
Analysis
Biggest Percent Gainers
Stocks With the Biggest Gains in a Given Period
Analysis
Thursday, April 16, 2026
RSI Crossed Below 50
Stocks Losing Momentum After Strength - RSI Cross Below 50
Analysis
First UT Bot Sell Signal After Biggest Gain
First UT Bot Sell Signal After the Biggest Percent Gain
Analysis
First UT Bot Sell Signal After Most Up Days
First UT Bot Sell Signal After an Extended Buy Streak
Analysis
Crossed Below 10 SMA
First Day Below 10 SMA After an Extended Run Above
Analysis
Biggest Percent Losers
Stocks With the Biggest Losses - Bearish Momentum and Risk Signals
Analysis
Wednesday, April 15, 2026
Breaking Higher Out Of Consolidation
Stocks Making New Highs - Bullish Momentum and Breakout Strength
Analysis
First Down Day After Most Up Days
First Down Day After the Longest Winning Streak
Analysis
Biggest Percent Losers
Stocks With the Biggest Losses - Bearish Momentum and Risk Signals
Analysis
Tuesday, April 14, 2026
The Strat 2 Up Reversal
Red Day Followed by a Bullish 2-Up Breakout That Closes Green
Analysis